These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 22554111)

  • 21. [Decision-making and apathy in early stage of Alzheimer's disease and in mild cognitive impairment].
    Jacus JP; Bayard S; Raffard S; Gély-Nargeot MC
    Geriatr Psychol Neuropsychiatr Vieil; 2013 Jun; 11(2):215-23. PubMed ID: 23803639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ecological assessment of mild cognitive impairment and Alzheimer disease using the Rivermead Behavioural Memory Test.
    Bolló-Gasol S; Piñol-Ripoll G; Cejudo-Bolivar JC; Llorente-Vizcaino A; Peraita-Adrados H
    Neurologia; 2014; 29(6):339-45. PubMed ID: 24139389
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and associated behavioral symptoms of depression in mild cognitive impairment and dementia due to Alzheimer's disease.
    Van der Mussele S; Bekelaar K; Le Bastard N; Vermeiren Y; Saerens J; Somers N; Mariën P; Goeman J; De Deyn PP; Engelborghs S
    Int J Geriatr Psychiatry; 2013 Sep; 28(9):947-58. PubMed ID: 23255479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the utility of everyday memory test and the Alzheimer's Disease Assessment Scale-Cognitive part for evaluation of mild cognitive impairment and very mild Alzheimer's disease.
    Adachi H; Shinagawa S; Komori K; Toyota Y; Mori T; Matsumoto T; Sonobe N; Kashibayashi T; Ishikawa T; Fukuhara R; Ikeda M
    Psychiatry Clin Neurosci; 2013 Apr; 67(3):148-53. PubMed ID: 23581865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Depressive symptoms influence global cognitive impairment indirectly by reducing memory and executive function in patients with mild cognitive impairment.
    Yatawara C; Lim L; Chander R; Zhou J; Kandiah N
    J Neurol Neurosurg Psychiatry; 2016 Dec; 87(12):1375-1383. PubMed ID: 28103200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AD dementia risk in late MCI, in early MCI, and in subjective memory impairment.
    Jessen F; Wolfsgruber S; Wiese B; Bickel H; Mösch E; Kaduszkiewicz H; Pentzek M; Riedel-Heller SG; Luck T; Fuchs A; Weyerer S; Werle J; van den Bussche H; Scherer M; Maier W; Wagner M;
    Alzheimers Dement; 2014 Jan; 10(1):76-83. PubMed ID: 23375567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of odor identification among amnestic and non-amnestic mild cognitive impairment, subjective cognitive decline, and early Alzheimer's dementia.
    Park SJ; Lee JE; Lee KS; Kim JS
    Neurol Sci; 2018 Mar; 39(3):557-564. PubMed ID: 29383614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening for Mild Cognitive Impairment Using the Dementia Rating Scale-2.
    Springate BA; Tremont G; Papandonatos G; Ott BR
    J Geriatr Psychiatry Neurol; 2014 Jun; 27(2):139-44. PubMed ID: 24578462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre-clinical AD, amnestic mild cognitive impairment and late-stage AD.
    Tramutola A; Triplett JC; Di Domenico F; Niedowicz DM; Murphy MP; Coccia R; Perluigi M; Butterfield DA
    J Neurochem; 2015 Jun; 133(5):739-49. PubMed ID: 25645581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Varying strength of cognitive markers and biomarkers to predict conversion and cognitive decline in an early-stage-enriched mild cognitive impairment sample.
    Egli SC; Hirni DI; Taylor KI; Berres M; Regeniter A; Gass A; Monsch AU; Sollberger M
    J Alzheimers Dis; 2015; 44(2):625-33. PubMed ID: 25322924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Memory impairment, in mild cognitive impairment without significant cerebrovascular disease, predicts progression to Alzheimer's disease.
    Lee YM; Park JM; Lee BD; Moon E; Chung YI; Kang CJ
    Dement Geriatr Cogn Disord; 2012; 33(4):240-4. PubMed ID: 22738930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cognitive impairment and its consequences in everyday life: experiences of people with mild cognitive impairment or mild dementia and their relatives.
    Johansson MM; Marcusson J; Wressle E
    Int Psychogeriatr; 2015 Jun; 27(6):949-58. PubMed ID: 25644289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characteristics of Mild Cognitive Impairment Using the Thai Version of the Consortium to Establish a Registry for Alzheimer's Disease Tests: A Multivariate and Machine Learning Study.
    Tunvirachaisakul C; Supasitthumrong T; Tangwongchai S; Hemrunroj S; Chuchuen P; Tawankanjanachot I; Likitchareon Y; Phanthumchinda K; Sriswasdi S; Maes M
    Dement Geriatr Cogn Disord; 2018; 45(1-2):38-48. PubMed ID: 29617684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conversion to dementia in mild cognitive impairment diagnosed with DSM-5 criteria and with Petersen's criteria.
    Marcos G; Santabárbara J; Lopez-Anton R; De-la-Cámara C; Gracia-García P; Lobo E; Pírez G; Menchón JM; Palomo T; Stephan BC; Brayne C; Lobo A;
    Acta Psychiatr Scand; 2016 May; 133(5):378-85. PubMed ID: 26685927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Visual Evaluation of Medial Temporal Lobe Atrophy as a Clinical Marker of Conversion from Mild Cognitive Impairment to Dementia and for Predicting Progression in Patients with Mild Cognitive Impairment and Mild Alzheimer's Disease.
    Persson K; Barca ML; Eldholm RS; Cavallin L; Šaltytė Benth J; Selbæk G; Brækhus A; Saltvedt I; Engedal K
    Dement Geriatr Cogn Disord; 2017; 44(1-2):12-24. PubMed ID: 28614836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreasing body mass index is associated with cerebrospinal fluid markers of Alzheimer's pathology in MCI and mild dementia.
    Mathys J; Gholamrezaee M; Henry H; von Gunten A; Popp J
    Exp Gerontol; 2017 Dec; 100():45-53. PubMed ID: 29054536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Motivational processes in mild cognitive impairment and Alzheimer's disease: results from the Motivational Reserve in Alzheimer's (MoReA) study.
    Forstmeier S; Maercker A
    BMC Psychiatry; 2015 Nov; 15():293. PubMed ID: 26578083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Within-Individual Variability: An Index for Subtle Change in Neurocognition in Mild Cognitive Impairment.
    Roalf DR; Quarmley M; Mechanic-Hamilton D; Wolk DA; Arnold SE; Moberg PJ;
    J Alzheimers Dis; 2016 Aug; 54(1):325-35. PubMed ID: 27567827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Behavioral and psychological symptoms and cognitive decline in patients with amnestic MCI and mild AD: a two-year follow-up study.
    Pocnet C; Antonietti JP; Donati A; Popp J; Rossier J; von Gunten A
    Int Psychogeriatr; 2015 Aug; 27(8):1379-89. PubMed ID: 25592615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New diagnostic criteria for Alzheimer's disease and mild cognitive impairment for the practical neurologist.
    Budson AE; Solomon PR
    Pract Neurol; 2012 Apr; 12(2):88-96. PubMed ID: 22450454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.